Trials / Unknown
UnknownNCT01867268
Effect of Acetazolamide & Position in CSF Leakage and Collection and Wound Dehiscence
Evaluating the Effect of Acetazolamide Administration and Prone Positioning Following Lumbosacral Spinal Surgery in Preventing Cerebro Spinal Fluid Leakage and Collection and Wound Dehiscence in Children.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 144 (estimated)
- Sponsor
- Tehran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
* Purpose of study : to determine the preventive effect of acetazolamide administration, prone positioning, and the combination of both following the neurosurgical interventions in lumbosacral region for cerebrospinal fluid (CSF) leak, CSF collection and wound dehiscence. * Sample size: 144 * intervention groups: * Group A: Acetazolamide administration for 10 days * Group B: prone positioning for 10 days * Group C: Acetazolamide administration and prone positioning for 10 days * Group D: no intervention * Period of study: Autumn 2012 to the end of winter of 2015
Detailed description
The purpose of this study is to evaluate the effect of Acetazolamide administration and prone positioning following lumbosacral spinal surgery in preventing cerebro-spinal fluid leakage and collection and wound dehissence in children admitted to Children Medical Center of Tehran since Autumn 2012 to the end of winter of 2015.The study is run under 4 categories of intervention: * Group A: Acetazolamide administration for 10 days * Group B: prone positioning for 10 days * Group C: Acetazolamide administration and prone positioning for 10 days * Group D: no intervention All patients are randomly assigned to these groups and when the patients faced with any of these complications, the protocol changes to Acetazolamide administration and prone positioning and the patient is considered as the failure of the protocol.
Conditions
- Fibrolipoma of Filum Terminale
- Lipomyelomeningocele
- Split Cord Malformation
- Dermal Sinus
- Tethered Cord Syndrome
- Tumor
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetazolamide | Acetazolamide administration for 10 days adjust dosage with weight of the patient |
| OTHER | prone positioning | prone positioning the patient for 10 days following the surgery |
| OTHER | Acetazolamide+ prone positioning | administration of acetazolamide and position the patient for 10 days following the surgery |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2015-04-01
- Completion
- 2015-09-01
- First posted
- 2013-06-03
- Last updated
- 2015-04-21
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01867268. Inclusion in this directory is not an endorsement.